134 related articles for article (PubMed ID: 2938524)
1. High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.
Yaksh TL; Harty GJ; Onofrio BM
Anesthesiology; 1986 May; 64(5):590-7. PubMed ID: 2938524
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine.
Yaksh TL; Harty GJ
J Pharmacol Exp Ther; 1988 Feb; 244(2):501-7. PubMed ID: 3346833
[TBL] [Abstract][Full Text] [Related]
3. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat.
Yaksh TL; Noueihed RY; Durant PA
Anesthesiology; 1986 Jan; 64(1):54-66. PubMed ID: 2867722
[TBL] [Abstract][Full Text] [Related]
4. Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist.
Ishikawa T; Marsala M; Sakabe T; Yaksh TL
Neuroscience; 2000; 95(3):781-6. PubMed ID: 10670445
[TBL] [Abstract][Full Text] [Related]
5. Spinal delivery of sufentanil, alfentanil, and morphine in dogs. Physiologic and toxicologic investigations.
Sabbe MB; Grafe MR; Mjanger E; Tiseo PJ; Hill HF; Yaksh TL
Anesthesiology; 1994 Oct; 81(4):899-920. PubMed ID: 7943841
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
Solomon RE; Gebhart GF
J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
[TBL] [Abstract][Full Text] [Related]
7. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism.
Sosnowski M; Yaksh TL
Anesth Analg; 1989 Nov; 69(5):587-92. PubMed ID: 2552866
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia induced by intrathecal opioids in mice: stereospecificity, drug specificity and effect of fasting.
Brase DA; Singha AK; Estrada U; Lux F; Dewey WL
J Pharmacol Exp Ther; 1990 Jun; 253(3):899-904. PubMed ID: 2359029
[TBL] [Abstract][Full Text] [Related]
9. Comparable dose-dependent inhibition of AP-7 sensitive strychnine-induced allodynia and paw pinch-induced nociception by mexiletine in the rat.
Khandwala H; Hodge E; Loomis CW
Pain; 1997 Sep; 72(3):299-308. PubMed ID: 9313270
[TBL] [Abstract][Full Text] [Related]
10. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat.
Sosnowski M; Yaksh TL
Anesthesiology; 1990 Dec; 73(6):1141-7. PubMed ID: 1978988
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.
Lux F; Han YH; Brase DA; Dewey WL
J Pharmacol Exp Ther; 1989 Jun; 249(3):688-93. PubMed ID: 2732944
[TBL] [Abstract][Full Text] [Related]
12. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
Barrett AC; Smith ES; Picker MJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
[TBL] [Abstract][Full Text] [Related]
13. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents.
Randich A; Thurston CL; Ludwig PS; Timmerman MR; Gebhart GF
Brain Res; 1991 Mar; 543(2):256-70. PubMed ID: 2059834
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists.
Yaksh TL
Pain; 1989 Apr; 37(1):111-123. PubMed ID: 2542867
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal transit following intrathecal or subcutaneous narcotic analgesics.
Dhasmana KM; Banerjee AK; Erdmann W
Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):152-61. PubMed ID: 2884939
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent effect of morphine and time-independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat.
Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
Anesthesiology; 1994 Jun; 80(6):1311-9. PubMed ID: 8010478
[TBL] [Abstract][Full Text] [Related]
17. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
[TBL] [Abstract][Full Text] [Related]
18. Differential behavioral effects induced by intrathecal microinjection of opiates: comparison of convulsive and cataleptic effects produced by morphine, methadone, and D-Ala2-methionine-enkephalinamide.
Frenk H; Watkins LR; Mayer DJ
Brain Res; 1984 May; 299(1):31-42. PubMed ID: 6326963
[TBL] [Abstract][Full Text] [Related]
19. The development of morphine tolerance and dependence in rats with chronic pain.
Yu W; Hao JX; Xu XJ; Wiesenfeld-Hallin Z
Brain Res; 1997 May; 756(1-2):141-6. PubMed ID: 9187324
[TBL] [Abstract][Full Text] [Related]
20. Separate neural mechanisms mediate sufentanil-induced pupillary responses in the cat.
Sharpe LG
J Pharmacol Exp Ther; 1991 Mar; 256(3):845-9. PubMed ID: 1672378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
